Home
ArticlesArticlesReproductive Technology Regulation in India establishes strict ethical, clinical, and legal standards for ART services, shaping who can access treatment, how clinics must operate, and how rights are protected. The framework aims to ensure safety while raising complex questions about inclusivity and evolving family structures.
India regulates assisted reproductive technology (ART) through a comprehensive legislative and regulatory framework designed to ensure ethical practices, prevent misuse, and protect the rights of all parties involved in fertility treatments.
The Assisted Reproductive Technology (Regulation) Act, 2021 is the primary legislation for reproductive technology regulation in India. This Act was passed by Parliament on December 20, 2021, and signed into law on December 18, 2021. It establishes a structured regulatory system with the central objective of regulating and supervising ART clinics and banks, preventing misuse, and ensuring safe and ethical practices for reproductive health.
Complementing this is the ART (Regulation) Rules, 2022, which provides detailed implementation guidelines and operational procedures for the Act.
The regulation is implemented through a two-tier governance system. The National ART and Surrogacy Board handles policy formulation and nationwide oversight, while State ART and Surrogacy Boards coordinate enforcement at the state level. These boards work with Appropriate Authorities designated in each state and union territory to oversee registration, compliance, and enforcement.
A National Registry of Banks and Clinics serves as a centralized database maintaining records of all registered ART clinics and banks across the country. This registry is accessible online through the National ART & Surrogacy Portal and acts as the central authority for clinic and bank registration information.
The Act establishes a two-level clinic classification system.
All ART clinics and banks must obtain mandatory registration with the National Registry to operate legally. Registration is valid for five years and can be renewed for an additional five years. Registration must be prominently displayed at the clinic or bank premises.
The registration process requires submission of applications through the Appropriate Authority in each jurisdiction, with applicants needing to meet specific staffing, infrastructure, equipment, and facility requirements. The Appropriate Authority must process applications within 30 days of receipt, and registration cannot be granted without a physical inspection of the premises by the State Board.
Access to ART services is restricted to specific categories of individuals.
Additionally, married couples must demonstrate infertility, defined as the inability to conceive after one year of unprotected coitus or the presence of a proven medical condition preventing conception.
The Act notably excludes unmarried men, single fathers, widowers, unmarried cohabiting couples, transgender individuals, and homosexual couples from accessing ART services, a provision that has drawn criticism regarding constitutional equality principles.
The Act includes provisions governing research involving human gametes, embryos, and gonadal tissues, ensuring that research is conducted ethically and in compliance with established guidelines.
The regulatory framework includes stringent enforcement mechanisms with significant penalties for violations.
For first-time violations of general provisions, offenders face fines ranging from ₹5 to ₹10 lakhs (approximately USD 6,000–12,000). Subsequent violations are punishable with imprisonment of 3 to 8 years plus fines ranging from ₹10 to ₹20 lakhs (USD 12,000–24,000).
For sex-selective ART violations, penalties are notably stricter, with imprisonment of 5 to 10 years, fines ranging from ₹10 to ₹25 lakhs (USD 12,000–30,000), or both.
Repeated offenses involving clinic or bank ownership can result in imprisonment of 8 to 12 years plus fines of ₹8 to ₹12 lakhs (USD 9,600–14,400).
Children born through ART are legally deemed to be biological children of the commissioning couple and are entitled to all rights and privileges available to natural children. Importantly, gamete donors have no parental rights over children born through the use of their genetic material.
ART clinics and banks must share specific information with the National Registry, including details about enrolled commissioning parties and donors, procedures undertaken, and procedural outcomes. However, this data collection requirement has raised concerns regarding the right to privacy, particularly regarding the mandatory collection of Aadhaar details from donors.
Despite being a comprehensive regulatory framework, the Act has several acknowledged limitations. The eligibility restrictions exclude significant populations from accessing ART services despite legal permission for adoption by unmarried individuals and single fathers under other Indian laws. Additionally, the Act does not include provisions regulating service costs, leaving pricing largely uncontrolled.
Boys treated for cancer before puberty cannot bank sperm, but freezing testicular tissue containing spermatogonial stem cells may one day restore their fertility. This article explains how the first transplants in adult survivors work, what the early research shows, the risks involved and why families should know about this option.
Microplastics have now been found in human follicular fluid and seminal fluid. This article explores the fast-growing body of research on microplastics and fertility, what scientists know and do not yet know about their effects on eggs and sperm, and practical, evidence-based ways that couples can reduce their everyday exposure.
Fertility conversations often focus on women, yet new research on sperm epigenetics shows a father's environment matters too. This article explains how air pollution may alter chemical marks on sperm DNA, why those changes could matter for fertility and pregnancy, and the practical steps men can reasonably consider before conception.
Donor eggs have long been seen as a way to reset the reproductive clock, but new research suggests uterine ageing also plays a role. This article explains what the latest evidence shows, how the ageing uterus may affect implantation and pregnancy, and how women in their late forties can prepare.
In vitro gametogenesis, the science of creating eggs and sperm from ordinary body cells, has moved from mouse studies towards human research. This article explains how the approaches work, what recent milestones really show, the obstacles that remain and why clinical use is still likely to be several years away.
Mitochondrial donation, often called three-parent IVF, has now produced the first detailed clinical results, with healthy children born to mothers at high risk of passing on mitochondrial disease. This article explains how the technique works, who it is for, what the evidence shows and which scientific questions remain open
A new AI sperm recovery technique is changing the outlook for men with azoospermia. This article explains how the STAR method scans semen samples for rare hidden sperm, what its first reported pregnancy means, who may benefit, and the key questions couples should raise with their own fertility specialist.
